Glenmark Pharma has confirmed a breakout from a rounding bottom pattern. Historically, similar breakouts in this stock have led to gains of up to 50%. With the current breakout, there is potential for history to repeat itself. At this stage, a 25% return appears achievable. Investors may consider gradually accumulating the stock.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.